Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Eiji Harada,1 Alexander Schacht,2 Tsukasa Koyama,3 Lauren Marangell,4,5 Toshinaga Tsuji,6 Rodrigo Escobar41Medical Science, Eli Lilly Japan K.K, Kobe, Japan; 2Global Statistical Sciences, Eli Lilly and Company, Bad Homburg, Germany; 3Clinical Research Center, Ohyachi Hospital, Sapporo, Japan; 4Eli...

Full description

Bibliographic Details
Main Authors:	Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-01-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/efficacy-comparison-of-duloxetine-and-ssris-atnbspdoses-approved-in-ja-peer-reviewed-article-NDT

Similar Items

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

SSRIs FOR DEPRESSION IN CHILDREN
by: Shalani Sinniah
Published: (2013-11-01)

Pharmacogenetics of SSRIs and Sexual Dysfunction
by: Liana Osis, et al.
Published: (2010-12-01)

Age related effects of SSRIs
by: Patil, Parag Ramchandra
Published: (2006)

Efficacy of duloxetine in achieving response and remission
by: Bauer Michael
Published: (2006-02-01)

Depression Treatment with Duloxetine and Reduction of Inability to Work
by: Michael Happich, et al.
Published: (2012-01-01)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
by: Daniela Rodrigues-Amorim, et al.
Published: (2020-10-01)

Duloxetine hydrochloride
by: Mohan Bhadbhade, et al.
Published: (2009-09-01)

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
by: Gillian E. Mead, et al.

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
by: Wohlreich Madelaine M, et al.
Published: (2005-01-01)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
by: Mikala C. Osani, et al.
Published: (2019-09-01)

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
by: Asaoka D, et al.
Published: (2015-03-01)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin
by: Enomoto H, et al.
Published: (2018-09-01)

Duloxetine induced hyponatremia
by: M Kulkarni
Published: (2015-01-01)

Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
by: Juan C Velasquez, et al.
Published: (2013-04-01)

Treating Chronic Pain with SSRIs: What Do We Know?
by: Elias Patetsos, et al.
Published: (2016-01-01)

SSRIs effekt och säkerhet hos barn och ungdomar
by: Angviken, Åsa
Published: (2016)

The change of gut microbiota in MDD patients under SSRIs treatment
by: Yang Shen, et al.
Published: (2021-07-01)

Selective Serotonin Re-uptake Inhibitors (SSRIs) Induced Weight Changes: A Dose and Duration Dependent Study on Albino Rats
by: Alka Aggarwal, et al.
Published: (2016-03-01)

Duloxetine: A Review of its Safety and Efficacy in the Management of Fibromyalgia Syndrome
by: Howard S. Smith, et al.
Published: (2010-01-01)

Duloxetine: A Review of Its Safety and Efficacy in the Management of Fibromyalgia Syndrome
by: Howard S. Smith, et al.
Published: (2010-12-01)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Lindsay Zilliox, et al.
Published: (2010-01-01)

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models
by: Yong Xu, et al.
Published: (2017-10-01)

Efficacy of Epalrestat, Duloxetine and Epalrestat in Combination with Methylcobalamine in Diabetic Peripheral Neuropathy
by: Abhilash Penchala, et al.
Published: (2016-12-01)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Russell J, et al.
Published: (2010-01-01)

Network meta-analysis of long-term efficacy of acupuncture-related therapies and SSRIs in treating post-stroke depression
by: Fan-Jie Xiong, et al.
Published: (2021-08-01)

Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
by: Zhang M, et al.
Published: (2015-06-01)

Comparison of efficacy, safety, and predictability of laser in situ keratomileusis using two laser suites
by: Meidani A, et al.
Published: (2016-08-01)

Is duloxetine an alternative in the treatment of osteoarthritis?
by: Joaquín Ananías, et al.
Published: (2017-10-01)

Duloxetine for the management of fibromyalgia syndrome
by: Beth A Scholz, et al.
Published: (2009-07-01)

Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT
by: David Kessler, et al.
Published: (2018-11-01)

SSRIs increase risk of blood transfusion in patients admitted for hip surgery.
by: Hermien Janneke Schutte, et al.
Published: (2014-01-01)

Bleeding gums: Duloxetine may be the cause
by: Balhara YPS, et al.
Published: (2007-01-01)

Duloxetine in the treatment of generalized anxiety disorder
by: Trevor R Norman, et al.
Published: (2009-01-01)

Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
by: Yakimova R., et al.
Published: (2020-11-01)

Isolating the Norepinephrine Pathway Comparing Lithium in Bipolar Patients to SSRIs in Depressive Patients
by: Andy R. Eugene, et al.
Published: (2015-07-01)

Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews
by: Áurea Dias de Farias, et al.
Published: (2020-07-01)

Comparison of duloxetine and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
by: Babij R, et al.
Published: (2015-05-01)

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls
by: Chen, P., et al.
Published: (2022)